US Patent Issued to Chimera Bioengineering on March 17 for "Compositions and methods for anti-TnMUC1 gold CAR t-cells" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,135, issued on March 17, was assigned to Chimera Bioengineering Inc..

"Compositions and methods for anti-TnMUC1 gold CAR t-cells" was invented by Benjamin Wang (Menlo Park, Calif.), Gusti Zeiner (Pacifica, Calif.), Albert Gacerez (Fremont, Calif.) and Eytan Herzig (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for delivering a payload at TnMUC1 positive cancer cells. Anti-TnMUC1 CARs and transgene payloads can be engineered into immune cells so that the transgene payload is expressed and delivered at desired times from the immune cell. Such anti-TnMUC1 CAR T-cells with transgene payloads can be combined w...